An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?

Peer Review reports

Original Submission
21 Jan 2022	Submitted	Original manuscript
10 Mar 2022	Reviewed	Reviewer Report - Peter James
8 Jun 2022	Reviewed	Reviewer Report - Christian Bröer
20 Jul 2022	Author responded	Author comments - Kilian Van Looy
Resubmission - Version 2
20 Jul 2022	Submitted	Manuscript version 2
Publishing
24 Jul 2022	Editorially accepted
15 Aug 2022	Article published	10.1186/s13690-022-00943-x

Back to article page